Greater potency of darbepoetin-αthan erythropoietin in suppression of serum hepcidin-25 and utilization of iron for erythropoiesis in hemodialysis patients-Reference-Cited by-同舟云学术

Greater potency of darbepoetin-αthan erythropoietin in suppression of serum hepcidin-25 and utilization of iron for erythropoiesis in hemodialysis patients

Published:2013-02-15 Issue:3 Volume:90 Page:237-244
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Shoji Shigeichi¹,Inaba Masaaki,Tomosugi Naohisa²,Okuno Senji¹,Ichii Mitsuru,Yamakawa Tomoyuki¹,Kurihara Satoshi³

Affiliation:

1. Shirasagi Hospital; Osaka; Japan

2. Division of Advanced Medicine; Medical Research Institute; Kanazawa Medical University; Ishikawa; Japan

3. Saitama-Tsukinomori Clinic; Saitama; Japan

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.12067/fullpdf

Reference32 articles.

1. Relationship between erythropoietin resistance index and left ventricular mass and function and cardiovascular events in patients on chronic hemodialysis;Chung;Hemodial Int,2012

2. CHOIR Investigators. Correction of anemia with epoetin alfa in chronic kidney disease;Singh;N Engl J Med,2006

3. Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure;Locatelli;Nephrol Dial Transplant,2004

4. KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease;National Kidney Foundation;Am J Kidney Dis,2006

5. Hepcidin as well as TNF-α are significant predictors of arterial stiffness in patients on maintenance hemodialysis;Kuragano;Nephrol Dial Transplant,2011

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Safety of Long‐Acting vs. Short‐Acting Erythropoiesis‐Stimulating Agents Among Patients Undergoing Hemodialysis;Clinical Pharmacology & Therapeutics;2024-04-17

2. Advancing Anemia Management in Chronic Kidney Disease: Assessing the Superiority of Darbepoetin Alfa Over Erythropoietin Alpha;Cureus;2024-01-03

3. Changes of biomarkers for erythropoiesis, iron metabolism, and FGF23 by supplementation with roxadustat in patients on hemodialysis;Scientific Reports;2023-02-23

4. Patient blood management when blood is not an option: a report of two cases;Annals of Palliative Medicine;2022-08

5. Efficacy and safety of darbepoetin alfa injection replacing epoetin alfa injection for the treatment of renal anemia in Chinese hemodialysis patients: A randomized, open‐label, parallel‐group, noninferiority phase III trial;Chronic Diseases and Translational Medicine;2022-04-18